NDC 63739-446-04 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63739-446
- Requested NDC
- 63739-446-04
- Package NDCs from labels
- 63739-446-10, 63739-446-04
- Manufacturer
- Cardinal Health
- Effective date
- 2019-08-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Potassium Chloride - Cardinal Health | Cardinal Health | 2019-08-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Potassium Chloride Extended-release Tablets, USP Microencapsulated | McKesson Packaging Services Business Unit of McKesson Corporation | 2014-02-05 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63739-446-10 | 2021-07-16 | C162847 | 48780-1 | 9855e2a2-3e82-60a7-e053-dbdaa90a05bd | Potassium Chloride Extended-release Tablets, USP Microencapsulated |
| 63739-446-10 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3e82-60a7-e053-dbdaa90a05bd | Potassium Chloride Extended-release Tablets, USP Microencapsulated |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63739-446-04 | EA - Each | 63739-446 | 90cf9dc5-dc63-470f-bf27-426702030826 | 1 | 2012-07-24 |
| 63739-446-10 | EA - Each | 63739-446 | dc11ed7a-3673-444c-99a2-3d3b92ea2f03 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 617303f8-4463-4a1e-a502-44abc181d91f | 2025-08-13 | Warnings | 660YQ98I10 |
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 03153d92-dc68-4b84-a8c9-634b1ffd7da1 | 2025-08-13 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Henry Schein, Inc. | bf8e8ac7-e6a8-4571-a0ea-7bcab89290f6 | 2025-08-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 3bdfced1-6e62-9e92-e063-6294a90a28aa | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3be29fcc-765e-8653-e063-6394a90a59d5 | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Slate Run Pharmaceuticals, LLC | 94ae03cc-b620-0dbb-e053-2a95a90a922c | 2025-08-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Slate Run Pharmaceuticals, LLC | 0cc57ece-f15a-4160-a5ea-8d6fa9f9e754 | 2025-08-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 47a87fb6-5e61-41c9-b759-10f7c74a67ce | 2025-08-05 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | American Health Packaging | 7956883f-0d31-4081-bbea-d9ea320a193b | 2025-08-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Marlex Pharmaceuticals Inc | 3e78028d-21a0-ba0f-e063-6294a90aac49 | 2025-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Marlex Pharmaceuticals, Inc. | 3e8a6f61-44eb-4b5a-e063-6294a90a4b1b | 2025-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3b403d60-4246-d765-e063-6394a90a12e8 | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | A-S Medication Solutions | 162a8ab5-76cf-48fa-8487-7780ed65647e | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | A-S Medication Solutions | 14db14ba-fd0d-4b2a-9f1c-a62b3b82306f | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 985a3341-0fe0-1dd6-e053-2a95a90ad2c5 | 2025-07-25 | Warnings | 660YQ98I10 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1b4e96-c96f-6424-e053-2991aa0aef30 | 2025-07-24 | Warnings | 660YQ98I10 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1a9ef9-9a54-5f94-e053-2a91aa0ab477 | 2025-07-24 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 8baf3f25-c78b-6c08-e053-2995a90a667e | 2025-07-23 | Warnings, Adverse reactions | ANDA074726 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 8bb030b7-104a-373b-e053-2995a90ab580 | 2025-07-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Guardian Drug Company | 296eda62-ea8e-7a0c-e063-6294a90a9274 | 2025-07-22 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.